Plasmodium Falciparum Infection and Interference with Effective B Cell Memory

恶性疟原虫感染和对有效 B 细胞记忆的干扰

基本信息

项目摘要

DESCRIPTION (provided by applicant): Naturally acquired immunity is critical in modulating morbidity and mortality from falciparum malaria in endemic areas, where some individuals are infected hundreds of times per year. Humoral responses to Plasmodium falciparum (Pf) are a critical component of this immunity, and Pf-specific memory B cells (MBCs) are likely important in the development and maintenance of an effective response. Unfortunately, protection from clinical disease takes many years to develop, during which time children living in endemic areas experience multiple episodes of symptomatic malaria, resulting in over 1 million deaths annually. Why does antimalarial immunity develop so slowly? One potential explanation is that Pf infection interferes with the development of effective B cell memory. An atypical phenotype of MBC, exhibiting evidence for lower affinity maturation and less capacity for differentiation into antibody secreting cells, has recently been described in the blood of HIV infected subjects. Recent studies have demonstrated that people living in malaria endemic areas have elevated frequencies of similar atypical MBCs, but the relationship between Pf exposure and frequencies of atypical MBCs has not been investigated in detail. Moreover, it is unclear what the consequences of these cells are in malaria infected individuals. We hypothesize that frequent exposure to Pf results in the selective diversion of Pf-specific B cells into an atypical MBC phenotype, delaying the acquisition of protective immunity to Pf. We are in a unique position to test this hypothesis, with access to a well characterized cohort of subjects living in an area of high but heterogeneous malaria transmission intensity and established laboratory infrastructure. Pf transmission intensity at our site in Tororo, Uganda ranks among the highest in the world, and preliminary data from this site suggest that affinity of Pf-specific antibody responses may be compromised in this setting. We will test our hypothesis with the following Specific Aims: 1) To measure the association between Pf exposure and enrichment of atypical memory B cells in children living in a high transmission region of Uganda.; and 2) To measure the association between enrichment of atypical memory B cells and serological and parasitological evidence of protective humoral immunity to malaria. We anticipate this study will show that increased exposure to Pf is associated with increased defects in B cell memory, characterized by higher proportions of Pf-specific MBCs showing an atypical phenotype and evidence of reduced Pf-specific antibody affinity and ability to control blood stage parasites. If so, counter to prevailig notions that malaria control efforts will delay the acquisition of immunity, strategies designed to reduce exposure may have a positive impact on immunity. In addition, methods to characterize Pf-specific B cells developed in this study will have broad application for investigating humoral immunity to Pf.
描述(由申请人提供):在疟疾流行地区,自然获得性免疫对于调节恶性疟疾的发病率和死亡率至关重要,在这些地区,有些人每年感染数百次。对恶性疟原虫(Pf)的体液应答是这种免疫的关键组成部分,而Pf特异性记忆B细胞(MBCs)可能在形成和维持有效应答中发挥重要作用。不幸的是,预防临床疾病需要多年时间才能形成,在此期间,生活在流行地区的儿童会多次出现有症状的疟疾,每年造成100多万人死亡。为什么抗疟疾免疫的发展如此缓慢?一种可能的解释是,Pf感染干扰了有效B细胞记忆的发展。最近在HIV感染者的血液中描述了MBC的非典型表型,显示出较低的亲和力成熟和较低的分化为抗体分泌细胞的能力。最近的研究表明,生活在疟疾流行地区的人出现类似非典型结核杆菌的频率较高,但尚未详细调查Pf暴露与非典型结核杆菌频率之间的关系。此外,目前还不清楚这些细胞对疟疾感染者的影响。我们假设,频繁暴露于Pf会导致Pf特异性B细胞选择性转向非典型MBC表型,延迟对Pf的保护性免疫的获得。我们处于一个独特的位置来验证这一假设,我们获得了一个生活在高但异质性疟疾传播强度地区的具有良好特征的受试者队列,并建立了实验室基础设施。我们在乌干达Tororo的站点的Pf传播强度是世界上最高的,该站点的初步数据表明,在这种情况下,Pf特异性抗体反应的亲和力可能受到损害。我们将通过以下具体目标来检验我们的假设:1)测量生活在乌干达高传播地区的儿童中Pf暴露与非典型记忆B细胞富集之间的关系;2)测量非典型记忆B细胞的富集与疟疾保护性体液免疫的血清学和寄生虫学证据之间的关系。我们预计这项研究将表明,暴露于Pf的增加与B细胞记忆缺陷的增加有关,其特征是Pf特异性MBCs的比例更高,表现出非典型表型,并且有证据表明Pf特异性抗体亲和力降低,控制血期寄生虫的能力降低。如果是这样,与疟疾控制努力将推迟获得免疫的普遍观念相反,旨在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bryan R Greenhouse其他文献

Bryan R Greenhouse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bryan R Greenhouse', 18)}}的其他基金

Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10190800
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10406294
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Drivers of strain-specific and strain-transcendent antimalarial immunity in childhood
儿童时期菌株特异性和菌株超越性抗疟免疫的驱动因素
  • 批准号:
    10630290
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Mentoring translational scientists in international infectious disease research
指导国际传染病研究中的转化科学家
  • 批准号:
    10320014
  • 财政年份:
    2019
  • 资助金额:
    $ 19.81万
  • 项目类别:
Mentoring translational scientists in international infectious disease research
指导国际传染病研究中的转化科学家
  • 批准号:
    10534671
  • 财政年份:
    2019
  • 资助金额:
    $ 19.81万
  • 项目类别:
Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination.
恶性疟原虫暴露的新型血清学检测可改善控制和消除监测。
  • 批准号:
    9107071
  • 财政年份:
    2016
  • 资助金额:
    $ 19.81万
  • 项目类别:
Plasmodium Falciparum Infection and Interference with Effective B Cell Memory
恶性疟原虫感染和对有效 B 细胞记忆的干扰
  • 批准号:
    8701920
  • 财政年份:
    2014
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    8110476
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    8321055
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:
Translational Studies of Plasmodium Falciparum Infection Dynamics
恶性疟原虫感染动力学的转化研究
  • 批准号:
    7676157
  • 财政年份:
    2008
  • 资助金额:
    $ 19.81万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 19.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了